Kv1.3 阻塞通过在脑内出血后通过NF-κB信号通路重塑M1/M2表型来缓解白质损伤
Bo Wang1, Jie Chen2, Shuhong Wang3
1Department of Neurosurgery and Key Laboratory of Neurotrauma, Southwest Hospital, Third Military Medical University (Army Medical University), 400038 Chongqing, China.
Journal of integrative neuroscience
|January 4, 2024
概括
用PAP-1阻断Kv1.3可减少脑内出血后的神经炎症和白质损伤. 这种治疗促进了有益的M2类微质分化,改善了神经系统的结果.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 脑内出血 (ICH) 往往会导致长期残疾,原因是基底质中的白质损伤 (WMI).
- 微质中的离子通道Kv1.3,加剧了ICH后的神经炎症.
研究的目的:
- 研究Kv1.3在ICH诱导的WMI和神经炎症中的作用.
- 评估阻断Kv1.3对微质偏振和WMI的治疗潜力.
主要方法:
- 构建了一个小鼠ICH模型,并通过免疫块,RT-qPCR和免疫染色测量Kv1.3表达.
- 进行PAP-1 (Kv1.3阻断剂) 和评估神经功能 (OFT,BMS) 的管理.
- 分析了炎症因子 (ELISA) 和微质极化 (免疫块,RT-qPCR,免疫染色) 以及NF-κB通路.
主要成果:
- ICH增加了血液瘤周围微质中的Kv1.3表达.
- PAP-1治疗显著改善了神经功能,并减少了WMI.
- 通过通过NF-κB抑制促进M2类微质极化,PAP-1降低了促炎性细胞因子和增加了抗炎因素.
结论:
- 使用PAP-1的Kv1.3阻塞改善了ICH后的WMI.
- PAP-1通过NF-κB通路促进M2类微质极化,减少炎症并改善结果.
相关概念视频
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Acute Inflammation II: Cellular Phase
The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...
Bacterial Meningitis II: Pathophysiology
Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...


